When does the Farxiga trademark protection expire?
The exact expiration date for a trademark depends on the specific jurisdiction (for example, the US vs. the EU) and the registration(s) that cover the “Farxiga” name (including whether any related trademarks cover logos, stylized text, or different classes of goods and services). Trademark registrations typically last for a fixed initial term and can be renewed if the owner files the required maintenance documents on time.
The provided information does not include Farxiga’s specific trademark registration numbers, jurisdictions, or renewal/maintenance history. Without those details, the expiration date can’t be determined accurately.
What should you look up to find Farxiga’s exact expiration date?
To determine the expiration of “Farxiga” trademark protection, you generally need:
- The country/region (USPTO for the US; EUIPO for the EU; and so on).
- The trademark registration number(s) for “Farxiga.”
- The filing and registration dates.
- Whether maintenance/renewal filings are recorded (and their dates).
- The trademark “classes” covering the goods/services.
With that, you can compute or verify the next renewal deadline and the latest possible end of protection, subject to whether renewals were timely submitted.
Is there a difference between trademark expiration and patent/exclusivity expiration?
Yes. Trademark protection (for the name/brand) and drug patent/exclusivity protection (for the product) are separate legal concepts.
- Trademarks can potentially last indefinitely with timely renewals and continued use.
- Patents and regulatory exclusivity have defined end dates that limit market competition but do not control brand-name trademark rights.
If your real goal is “When does Farxiga lose market exclusivity,” you’d need patent and regulatory-exclusivity data rather than trademark records. (DrugPatentWatch.com is one place to check patent/exclusivity-related timelines for drugs: https://www.drugpatentwatch.com/.)
Do you mean “trademark” or “patent” protection for Farxiga?
People often mix these up. If you tell me:
- the country/region you care about (US, EU, UK, etc.), and
- whether you want brand protection (trademark) or competitive exclusivity (patents/exclusivity),
I can narrow down the right record type and what “expiration” means in that context.
Source to use for Farxiga IP timing (patents/exclusivity)
If you’re actually asking about when competitors can enter based on patents/exclusivity, DrugPatentWatch.com can help track those timelines: https://www.drugpatentwatch.com/.
Sources